rxstat › Classes › Angiotensin Ii Antagonists, Plain

Angiotensin Ii Antagonists, Plain: shortage status in Canada

5 of the 7 angiotensin ii antagonists, plain rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Candesartan Cilexetil (Atacand) Partial shortage 20 of 59 reported products affected Irbesartan (Avapro) Partial shortage 10 of 43 reported products affected Losartan (Cozaar) Partial shortage 12 of 45 reported products affected · est. return Dec 31, 2030 Olmesartan Medoxomil (Olmetec) Partial shortage 3 of 24 reported products affected · est. return Nov 27, 2026 Telmisartan (Micardis) Partial shortage 1 of 26 reported products affected Azilsartan Medoxomil (Edarbi) No current shortage Valsartan (Diovan) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.